INDIAN DRUGS & PHARMACEUTICAL LTD. vs FAMY CARE .

The Supreme Court upheld the Delhi High Court's decision to quash the Rate Contract No. S-140013/4/2008-OP/100 dated 2nd December 2008, which had awarded 175 lakhs cycles of various OCP brands to Indian Drugs & Pharmaceutical Ltd. (IDPL). The Court found that the tender process was flawed as it favored IDPL under the Purchase Preference Policy, which was not applicable to the circumstances of the case. The ruling emphasized the need for fair competition in public procurement, particularly in the context of family planning products supplied to the Union of India.